ArticleEnvironmental science & technology2026
Prenatal Internal Exposure to Polycyclic Aromatic Hydrocarbons, Maternal Genetic Susceptibility, and Child Growth Trajectories: Evidence from a Prospective Cohort Study.
Article in Environmental science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) is a widespread environmental health concern, yet its impact on early childhood growth trajectories remains poorly understood. In a prospective birth cohort in China (PKUBC-T), we identified distinct growth trajectories from birth to age 3 years using K-means clustering for longitudinal data (N = 1467) and measured 16 plasma PAHs in first-trimester maternal samples (N = 333). Twenty maternal single nucleotide polymorphisms (SNPs) related to PAHs metabolism were genotyped. Modified Poisson and weighted quantile sum regression showed that higher prenatal PAHs exposure was associated with increased risk of rapid higher growth trajectory, with phenanthrene, pyrene, and fluoranthene contributing most. This trajectory is characterized by a marginally higher BMI Z-score at birth, followed by rapid growth during infancy and sustained high levels thereafter. Furthermore, the AHR rs2066853 variant significantly modified the association, with the positive association being observed only among mothers carrying GA/AA genotypes (RR, 2.44; 95% CI, 1.51-3.97) but not among those with GG homozygotes (P for interaction is 0.049). We provide evidence that prenatal PAHs exposure may alter early childhood growth patterns, with effects modified by maternal genetic susceptibility. If confirmed, these findings highlight the mechanistic importance of AHR signaling in environmental developmental toxicity and underscore the need for exposure reduction and targeted maternal monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.